Registration is now open for the 2nd annual Wearable Injectors and Connected Devices Conference 2020 Read more
FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor Read more
Takeda China announces ADCETRIS (brentuximab vedotin) is approved for the treatment of adult patients with CD30-positive Lymphomas Read more
Recursion Enters Into Global Licensing Agreement with Takeda to Develop TAK-733 in Hereditary Cancer Syndrome Read more
Neuraptive Therapeutics Announces FDA has Granted Fast Track Designation to NTX-001 Clinical Development Program for Treatment of Patients with Peripheral Nerve Injuries Read more